BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 19074475)

  • 1. Interleukin-6 overexpression induces pulmonary hypertension.
    Steiner MK; Syrkina OL; Kolliputi N; Mark EJ; Hales CA; Waxman AB
    Circ Res; 2009 Jan; 104(2):236-44, 28p following 244. PubMed ID: 19074475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of interleukin-6 on hypoxia-induced pulmonary hypertension and lung inflammation in mice.
    Savale L; Tu L; Rideau D; Izziki M; Maitre B; Adnot S; Eddahibi S
    Respir Res; 2009 Jan; 10(1):6. PubMed ID: 19173740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of bcr and abr promotes hypoxia-induced pulmonary hypertension in mice.
    Yu M; Gong D; Lim M; Arutyunyan A; Groffen J; Heisterkamp N
    PLoS One; 2012; 7(11):e49756. PubMed ID: 23152932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of LR11 Attenuates Hypoxia-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation With Medial Thickening in Mice.
    Jiang L; Konishi H; Nurwidya F; Satoh K; Takahashi F; Ebinuma H; Fujimura K; Takasu K; Jiang M; Shimokawa H; Bujo H; Daida H
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1972-9. PubMed ID: 27493099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial Krüppel-like factor 4 modulates pulmonary arterial hypertension.
    Shatat MA; Tian H; Zhang R; Tandon G; Hale A; Fritz JS; Zhou G; Martínez-González J; Rodríguez C; Champion HC; Jain MK; Hamik A
    Am J Respir Cell Mol Biol; 2014 Mar; 50(3):647-53. PubMed ID: 24156273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smooth Muscle Insulin-Like Growth Factor-1 Mediates Hypoxia-Induced Pulmonary Hypertension in Neonatal Mice.
    Sun M; Ramchandran R; Chen J; Yang Q; Raj JU
    Am J Respir Cell Mol Biol; 2016 Dec; 55(6):779-791. PubMed ID: 27438786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interruption of vascular endothelial growth factor receptor 2 signaling induces a proliferative pulmonary vasculopathy and pulmonary hypertension.
    Winter MP; Sharma S; Altmann J; Seidl V; Panzenböck A; Alimohammadi A; Zelniker T; Redwan B; Nagel F; Santer D; Stieglbauer A; Podesser B; Sibilia M; Helbich T; Prager G; Ilhan-Mutlu A; Preusser M; Lang IM
    Basic Res Cardiol; 2020 Sep; 115(6):58. PubMed ID: 32880713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells.
    Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Intersectin-1s Lung Expression Induces Obliterative Remodeling and Severe Plexiform Arteriopathy in the Murine Pulmonary Vascular Bed.
    Patel M; Predescu D; Bardita C; Chen J; Jeganathan N; Pritchard M; DiBartolo S; Machado R; Predescu S
    Am J Pathol; 2017 Mar; 187(3):528-542. PubMed ID: 28068512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced mitogenic factor (HIMF/FIZZ1/RELMα) in chronic hypoxia- and antigen-mediated pulmonary vascular remodeling.
    Angelini DJ; Su Q; Yamaji-Kegan K; Fan C; Skinner JT; Poloczek A; El-Haddad H; Cheadle C; Johns RA
    Respir Res; 2013 Jan; 14(1):1. PubMed ID: 23289668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of the adenosine A2A receptor confers pulmonary arterial hypertension and increased pulmonary vascular remodeling in mice.
    Xu MH; Gong YS; Su MS; Dai ZY; Dai SS; Bao SZ; Li N; Zheng RY; He JC; Chen JF; Wang XT
    J Vasc Res; 2011; 48(2):171-83. PubMed ID: 20938208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative mutation of the TGF-beta receptor blocks hypoxia-induced pulmonary vascular remodeling.
    Chen YF; Feng JA; Li P; Xing D; Zhang Y; Serra R; Ambalavanan N; Majid-Hassan E; Oparil S
    J Appl Physiol (1985); 2006 Feb; 100(2):564-71. PubMed ID: 16223981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
    Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
    Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.
    Ogura S; Shimosawa T; Mu S; Sonobe T; Kawakami-Mori F; Wang H; Uetake Y; Yoshida K; Yatomi Y; Shirai M; Fujita T
    Am J Physiol Heart Circ Physiol; 2013 Jul; 305(2):H155-62. PubMed ID: 23686713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
    de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
    Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin.
    Van Hung T; Emoto N; Vignon-Zellweger N; Nakayama K; Yagi K; Suzuki Y; Hirata K
    Life Sci; 2014 Nov; 118(2):313-28. PubMed ID: 24412382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.
    Cuttica MJ; Langenickel T; Noguchi A; Machado RF; Gladwin MT; Boehm M
    Am J Respir Cell Mol Biol; 2011 Jul; 45(1):62-71. PubMed ID: 20813993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of EC-SOD worsens alveolar and vascular development in a neonatal mouse model of bleomycin-induced bronchopulmonary dysplasia and pulmonary hypertension.
    Delaney C; Wright RH; Tang JR; Woods C; Villegas L; Sherlock L; Savani RC; Abman SH; Nozik-Grayck E
    Pediatr Res; 2015 Dec; 78(6):634-40. PubMed ID: 26322414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PKG-1α leucine zipper domain defect increases pulmonary vascular tone: implications in hypoxic pulmonary hypertension.
    Ramchandran R; Raghavan A; Geenen D; Sun M; Bach L; Yang Q; Raj JU
    Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(7):L537-44. PubMed ID: 25128522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.